NASDAQ:KDNY - Nasdaq - US16961L1061 - Common Stock - Currency: USD
These stocks climbed 74% and 78% over the past month and there could be more gains ahead.
Mentions: VERA
SEATTLE, July 28, 2023 (GLOBE NEWSWIRE) -- Chinook Therapeutics, Inc. (Nasdaq: KDNY), a biopharmaceutical company focused on the discovery, development...
/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...
/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Chinook Therapeutics, Inc. ("Chinook" or the "Company") (NASDAQ: KDNY). Such...
/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...
/PRNewswire/ -- Moore Kuehn, PLLC, a law firm focusing in securities litigation located on Wall Street in downtown New York City, is investigating potential...
/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Chinook Therapeutics, Inc. ("Chinook" or the "Company") (NASDAQ: KDNY). Such...
/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...
Chinook Therapeutics has a history of being opportunistic. Now, it's joining forces with Novartis.
/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...
/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...
/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Chinook Therapeutics, Inc. ("Chinook" or the "Company") (NASDAQ: KDNY). Such...
The company announced early phase 2 trials information regarding its lead therapy.
/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...
CHK-336 was generally well tolerated in healthy volunteers (HV) who received single doses up to 500 mg and multiple doses up to 60 mg for 14...
Stocks kept powering higher despite, but the Nasdaq is looking extended.
/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Chinook Therapeutics, Inc. ("Chinook" or the "Company") (NASDAQ: KDNY). Such...
/PRNewswire/ -- Moore Kuehn, PLLC, a law firm focusing in securities litigation located on Wall Street in downtown New York City, is investigating potential...